RemeGen
As of the edition of 20 October 2026, RemeGen runs 20 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 15 |
| Stopped | 1 |
| Status not established | 4 |
| Total | 20 |
Where its trials are
- Cancer: 33 trials led
- Skin and connective tissue: 12 trials led
- Digestive system: 11 trials led